"eyeMax Insight" Cholangioscopy for Unexplained Bile Duct Stenosis
NCT ID: NCT05905744
Last Updated: 2023-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
157 participants
OBSERVATIONAL
2023-06-30
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contribution of the EyeMAX™ 11Fr (Micro-Tech) Digital Single-Operator Cholangioscope With a Wide Working Channel
NCT06933576
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma
NCT05993429
The Application of Ultrasound in the Evaluation of Patients With Colon Cancer-related Obstruction Receiving Colonic Stent Placement
NCT06997848
Transparent Cap-assisted SpyGlass for Biliary Stricture
NCT05320497
Prospective Study on Double-Stapling End-to-End Gastroduodenostomy Billroth-I Anastomosis in Laparoscopy-Assisted Surgery for Locally Advanced Distal Gastric Cancers
NCT05545293
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The etiology of biliary strictures is complex, including not only malignant tumors , but also factors such as stones, inflammatory strictures, congenital variations and so on. Currently, the main methods for diagnosing malignant biliary obstruction in clinical practice include clinical examinations, biochemical testing (such as serum CA19-9), imaging, and endoscopic retrograde cholangiopancreatography (ERCP). However, these methods have limitations, such as the limited specificity and sensitivity of CA19-9 and the indirect imaging of ERCP after contrast agent filling. Therefore, these methods are relatively difficult to distinguish the benign and malignant nature of biliary lesions. This study intends to analyze the diagnostic value of the biliary endoscopy system for these unexplained bile duct stenosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with unexplained bile duct stenosis
Patients with unexplained bile duct stenosis undergo cholangioscopy examination and ERCP
cholangioscopy
cholangioscopy examination and forceps biopsy, followed by brush biopsy from ERCP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cholangioscopy
cholangioscopy examination and forceps biopsy, followed by brush biopsy from ERCP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with mental illness; ③ Previously underwent choledochoscopy examination; ④ Malignant biliary obstruction;
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oriental Hepatobiliary Surgery Hospital Affiliated to Naval Military Medical University
UNKNOWN
Zhejiang University
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
West China Hospital
OTHER
LanZhou University
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Peking University Cancer Hospital & Institute
OTHER
First Hospital of China Medical University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
The Second Affiliated Hospital of Baotou Medical College
OTHER
Shandong Province Third hospital
OTHER
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhaoshen Li
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yunfeng Wang, Doctor
Role: PRINCIPAL_INVESTIGATOR
Changhai Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
eyeMAX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.